Shares of Nxera Pharma Co., Ltd. (OTCMKTS:SOLTF – Get Free Report) crossed below its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $9.56 and traded as low as $7.00. Nxera Pharma shares last traded at $7.13, with a volume of 2,400 shares trading hands.
Nxera Pharma Stock Performance
The stock has a 50-day moving average price of $9.14 and a 200-day moving average price of $9.56.
Nxera Pharma Company Profile
Nxera Pharma Co, Ltd. develops and sells biopharmaceutical products in Japan, Switzerland, the United States, Bermuda, and the United Kingdom. Its product portfolio products include Ultibro/Breezhaler and Seebri/Breezhaler for the treatment of chronic obstructive pulmonary disease; Enerzair and Breezhaler for the treatment of asthma; ORAVI, a novel formulation for the treatment of oropharyngeal candidiasis; and PIVLAZ for the treatment of cerebral vasospasm indications.
Recommended Stories
- Five stocks we like better than Nxera Pharma
- Learn Technical Analysis Skills to Master the Stock Market
- Taiwan Semiconductor Soars on Earnings With More Room to Run
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- Is Lucid Group Nearing the Bottom? What Investors Should Know
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- 90% Gain Possible? Analysts Are Bullish on Joby Aviation
Receive News & Ratings for Nxera Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nxera Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
